Obesity, insulin resistance, and skeletal muscle nitric oxide synthase.
The molecular mechanisms responsible for impaired insulin action have yet to be fully identified. Rodent models demonstrate a strong relationship between insulin resistance and an elevation in skeletal muscle inducible nitric oxide synthase (iNOS) expression; the purpose of this investigation was to explore this potential relationship in humans. Sedentary men and women were recruited to participate (means ± SE: nonobese, body mass index = 25.5 ± 0.3 kg/m(2), n = 13; obese, body mass index = 36.6 ± 0.4 kg/m(2), n = 14). Insulin sensitivity was measured using an intravenous glucose tolerance test with the subsequent modeling of an insulin sensitivity index (S(I)). Skeletal muscle was obtained from the vastus lateralis, and iNOS, endothelial nitric oxide synthase (eNOS), and neuronal nitric oxide synthase (nNOS) content were determined by Western blot. S(I) was significantly lower in the obese compared with the nonobese group (~43%; P < 0.05), yet skeletal muscle iNOS protein expression was not different between nonobese and obese groups. Skeletal muscle eNOS protein was significantly higher in the nonobese than the obese group, and skeletal muscle nNOS protein tended to be higher (P = 0.054) in the obese compared with the nonobese group. Alternative analysis based on S(I) (high and low tertile) indicated that the most insulin-resistant group did not have significantly more skeletal muscle iNOS protein than the most insulin-sensitive group. In conclusion, human insulin resistance does not appear to be associated with an elevation in skeletal muscle iNOS protein in middle-aged individuals under fasting conditions.
Department of Kinesiology, East Carolina University, Greenville, North Carolina 27858, USA.
Raymond M
RM
Kraus
Joseph A
JA
Houmard
William E
WE
Kraus
Charles J
CJ
Tanner
Joseph R
JR
Pierce
Myung Dong
MD
Choi
Robert C
RC
Hickner
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D015331:Cohort Studies; D005080:Exercise Test / Q000379:methods; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000201:enzymology*; D019001:Nitric Oxide Synthase / Q000097:blood / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I / Q000097:blood / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II / Q000097:blood / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000097:blood / Q000378:metabolism*; D009765:Obesity / Q000097:blood / Q000201:enzymology*
D001786:Blood Glucose; C496319:NOS2 protein, human; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III